06/09/2022Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
05/19/2022Immunome Announces Data Demonstrating COVID-19 Antibody Cocktail Potently Clears Omicron BA.1 Variant in Hamster Model and Retains Activity Against BA.2 Subvariant
03/11/2022FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
02/08/2022Immunome’s Antibody Cocktail Effective Against SARS-CoV-2 Omicron Variant in In Vitro Live Virus Testing
01/10/2022Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19
